Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Effectiviteit van amiloride, fluoxetine en riluzol bij secundair progressieve MS (SPMS)
mrt 2020 | Multipele Sclerose